Home › Stocks › IBRX › All Fund Holders
IBRX — IMMUNITYBIO INC · All Fund Holders
Funds holding (latest): 37 · Reported value held: $982.92M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 34.08M | $298.40M | 0.01% | Add |
| D. E. Shaw & Co history | Q2 2026 | 11.55M | $101.13M | 0.05% | Reduce |
| Two Sigma Investments history | Q2 2026 | 11.10M | $97.16M | 0.07% | Add |
| Geode Capital Management history | Q2 2026 | 9.85M | $86.23M | 0.01% | Add |
| Vanguard Group history | Q4 2025 | 32.78M | $64.90M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 5.67M | $49.68M | 0.01% | Add |
| Millennium Management history | Q2 2026 | 5.58M | $48.85M | 0.02% | Add |
| Northern Trust Corp history | Q2 2026 | 3.57M | $31.21M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 3.43M | $30.05M | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 3.23M | $28.32M | 0.00% | Hold |
| UBS Group AG history | Q2 2026 | 3.20M | $27.98M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 2.89M | $25.29M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 2.18M | $19.13M | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 1.45M | $12.87M | 0.00% | New |
| BNY Mellon history | Q2 2026 | 1.31M | $11.51M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 1.03M | $9.01M | 0.01% | New |
| Wells Fargo & Co history | Q2 2026 | 737.03K | $6.45M | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 650.28K | $5.69M | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 582.18K | $5.10M | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 487.57K | $4.27M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 441.70K | $3.87M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 302.99K | $2.65M | 0.00% | Add |
| Legal & General Investment Management America history | Q2 2026 | 278.27K | $2.44M | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 243.68K | $2.13M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 222.86K | $1.95M | 0.00% | Add |
| Janus Henderson Group history | Q1 2026 | 157.44K | $1.20M | 0.00% | Add |
| Point72 Asset Management history | Q2 2026 | 132.00K | $1.16M | 0.00% | Reduce |
| Wellington Management Group history | Q2 2026 | 110.68K | $969.04K | 0.00% | Reduce |
| Prudential Financial history | Q2 2026 | 103.67K | $907.63K | 0.00% | Reduce |
| Balyasny Asset Management history | Q2 2026 | 83.58K | $731.78K | 0.00% | Reduce |
| CPP Investments history | Q2 2026 | 70.20K | $614.60K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 39.52K | $346.02K | 0.00% | Add |
| Principal Global Investors history | Q2 2026 | 29.56K | $258.78K | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 29.49K | $258.21K | 0.00% | Reduce |
| Amundi US history | Q1 2026 | 16.53K | $126.75K | 0.00% | New |
| Lazard Asset Management history | Q4 2025 | 35.12K | $69.55K | 0.00% | Hold |
| T. Rowe Price Associates history | Q2 2026 | 441.44K | $3.87K | 0.00% | Add |